在没有心房节奏需要的患者中,使用双室发生器的经济高效的CRT
Pedro J Diaz Delgado1, Aashish Katapadi2, Douglas Darden1
1Kansas City Heart Rhythm Institute, 5100 W 110th Street, Suite 200, Overland Park, KS, 66211, USA.
概括
通过左捆分支区域节奏来重新利用双腔器件进行心脏再同步治疗 (CRT) 是安全且具有成本效益的. 这种方法可以扩大CRT的访问减少喷射分数的患者,特别是在资源有限的地区.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电子生理学 电子生理学
背景情况:
- 心脏再同步疗法 (CRT) 改善了左心室喷射分数 (LVEF) 减少的患者的结果.
- 高昂的设备成本可能会限制CRT的可访问性.
- 需要使用替代步调策略来扩大CRT接入.
研究的目的:
- 评估使用双室心脏起器或可植入心脏转换器-除器 (ICD) 的心脏前庭端口用于左束支部区域节奏 (LBBAP) 以提供CRT的可行性,安全性和成本效益.
- 评估这项LBBAP策略对LVEF和QRS持续时间的影响.
主要方法:
- 用双室发电机对18名接受LBBAP治疗的患者进行了回顾性分析.
- 为左捆分支节奏带重新使用心脏口.
- 在12个月内评估LVEF,QRS持续时间和并发症.
- 成本分析,将重新设计的策略与标准CRT设备进行比较.
主要成果:
- 通过重新设计的双室发电机进行LBBAP是可行的和安全的,没有程序内并发症.
- 在心脏起器患者中,左心室喷射分数 (LVEF) 保持稳定;有限的ICD数据表明LVEF有所改善.
- 观察到适度的QRS缩小.
- 与标准CRT-D和CRT-P设备相比,证明了显著的成本节约.
结论:
- 通过LBBAP通过双室发电机输送CRT对于没有心房节奏需求的患者来说是一个可行的,安全的和具有成本效益的替代方案.
- 这一战略有可能提高CRT的可访问性,特别是在资源有限的环境中.
- 需要进行更大规模的研究来验证这些发现.
更多相关视频
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427
Cardiomyopathy V: Interprofessional Care
305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305
Dysrhythmias VI: Management of Dysrhythmias
373
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
373
Heart Failure VI: Adjunct Therapies
228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Cardiopulmonary Resuscitation III: AED Use
473
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
473


